| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |